Zu unserem Team

Charlotte Delphis

Associate

Charlotte is an associate at Oaklins France. Her primary M&A focus is in the agriculture/agtech, healthy food and consumer healthcare sectors. Notable deals she has advised on include the sale of Vitibot to SAME Deutz-Fahr, the sale of Qilibri to SP2L Group, the sale of Innoxa to Biosynex Group, the sale of Stardea to EA Pharma Group, the sale of Phytogenese Laboratories to Inostrale Group, Natimpact’s acquisition of Base Organic Food and Naturopera’s fundraising from Turenne Group and Ecorobotix Series B to finance its production site.

Prior to joining the firm in 2020, Charlotte worked as an M&A analyst at Kepler Cheuvreux Switzerland and Neuflize OBC, and as an equity research analyst in the energy sector at Natixis. She has a master’s in finance from TBS Business School.

 Charlotte Delphis
Standort
Paris, Frankreich

E-Mail


Telefon
+33 1 43 12 32 12

Private Equity | Landwirtschaft | Konsumgüter & Handel | Lebensmittel- und Getränkeindustrie

Acquisition of Base Organic Food by Natimpact

Weitere Informationen
Konsumgüter & Handel | Lebensmittel- und Getränkeindustrie | Gesundheitswesen | Technologie, Medien und Telekommunikation

Qilibri has been acquired by SP2L (NaturAvignon Laboratory)

Weitere Informationen
Konsumgüter & Handel | Gesundheitswesen

Innoxa has sold its eye care activity to Biosynex Group

Weitere Informationen